Strasser S, Sheil A G, Gallagher N D, Waugh R, McCaughan G W
A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, New South Wales, Australia.
J Gastroenterol Hepatol. 1993 May-Jun;8(3):238-43. doi: 10.1111/j.1440-1746.1993.tb01193.x.
Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are the most common cholestatic disorders in adulthood requiring hepatic transplantation. Although they run similar courses, they may have different problems before and after transplantation. The aim of this study was to compare pre- and post-transplant complications and outcomes in these two similar but distinct patient groups. One hundred and seventeen adult patients underwent liver transplantation at our institution over a 6 year period, including 19 with PSC and 20 with PBC. Pre-transplant there were no significant differences in age, liver biochemistry, haematology or Child-Pugh scores between the two groups. The mean duration of disease before transplant was longer in PSC patients (11.7 vs 6.5 years; P < 0.05). The prevalence of septic cholangitis was greater in PSC (58 vs 5%; P < 0.01) as was the requirement for surgical or radiological interventional procedures, excluding cholecystectomy (53 vs 0%; P < 0.01). At transplantation, four patients with PSC had previously unrecognized cholangiocarcinoma. In the pre-transplant period these four patients had uncontrolled biliary sepsis at the time of transplant vs five of 15 PSC patients without cholangiocarcinoma. Postoperatively, PSC patients had a greater prevalence of intra-abdominal sepsis requiring surgical or radiological intervention (42 vs 5%; P < 0.05). In comparison, patients with PBC had a high prevalence of skeletal complications (30 vs 10%; P < 0.05) particularly avascular necrosis (15 vs 0%). The prevalence of chronic rejection was similar in both groups (15%). Overall survival was higher in PBC patients (85 vs 63%; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
原发性硬化性胆管炎(PSC)和原发性胆汁性肝硬化(PBC)是成年期最常见的需要肝移植的胆汁淤积性疾病。尽管它们病程相似,但在移植前后可能存在不同问题。本研究的目的是比较这两个相似但不同的患者群体移植前后的并发症及结局。在6年期间,117例成年患者在我们机构接受了肝移植,其中19例为PSC患者,20例为PBC患者。移植前,两组在年龄、肝脏生化指标、血液学指标或Child-Pugh评分方面无显著差异。PSC患者移植前疾病的平均持续时间更长(11.7年对6.5年;P<0.05)。PSC患者中化脓性胆管炎的患病率更高(58%对5%;P<0.01),除胆囊切除外的手术或放射介入治疗需求也更高(53%对0%;P<0.01)。移植时,4例PSC患者此前未被识别出胆管癌。在移植前阶段,这4例患者在移植时存在未控制的胆系感染,而15例无胆管癌的PSC患者中有5例存在该情况。术后,PSC患者腹腔内感染需要手术或放射介入治疗的患病率更高(42%对5%;P<0.05)。相比之下,PBC患者骨骼并发症的患病率较高(30%对10%;P<0.05),尤其是无血管性坏死(15%对